TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer
Clinical trial NCT03140553 · COMPLETED
Trial details
- NCT number
- NCT03140553
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-11-11
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.